Voyager Therapeutics (MEX:VYGR) Change In Inventory: MXN0.0 Mil (TTM As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

MEX:VYGR Voyager Therapeutics Inc MEX:VYGR
52 GF Score
Price MXN63.00
GF Value MXN30.50
! 6 Warning Signs
View Full Analysis

What is Voyager Therapeutics Change In Inventory?

Voyager Therapeutics MEX:VYGR 52 Change In Inventory is MXN0.0 Mil as of Jun. 2026. GuruFocus rates MEX:VYGR with a GF Score™ of 52/100 and a GF Value™ of MXN30.50. The stock has 6 warning signs investors should review.

Voyager Therapeutics's change in inventory for the quarter that ended in Jun. 2026 was MXN0.0 Mil. It means Voyager Therapeutics's inventory stayed the same from Mar. 2026 to Jun. 2026 .

Voyager Therapeutics's change in inventory for the fiscal year that ended in Dec. 2025 was MXN0.0 Mil. It means Voyager Therapeutics's inventory stayed the same from Dec. 2024 to Dec. 2025 .

Voyager Therapeutics's Total Inventories for the quarter that ended in Jun. 2026 was MXN0.0 Mil.

Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

Inventory Turnover measures how fast the company turns over its inventory within a year.

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue. Voyager Therapeutics's Inventory-to-Revenue for the quarter that ended in Jun. 2026 was 0.00.

Voyager Therapeutics  (MEX:VYGR) Change In Inventory Explanation

1. Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

Voyager Therapeutics's Days Inventory for the quarter that ended in is calculated as:

Days Inventory=Average Total Inventories/Cost of Goods Sold*Days in Period
=0/0*365 / 4
=N/A

2. Inventory Turnover measures how fast the company turns over its inventory within a year.

Voyager Therapeutics's Inventory Turnover for the quarter that ended in Jun. 2026 is calculated as

Inventory Turnover=Cost of Goods Sold / Average Total Inventories
=0 / 0
=N/A

3. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

Voyager Therapeutics's Inventory to Revenue for the quarter that ended in Jun. 2026 is calculated as

Inventory-to-Revenue=Average Total Inventories / Revenue
=0 / 55.226
=0.00

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Voyager Therapeutics Change In Inventory Related Terms

Voyager Therapeutics Change In Inventory Historical Data

* Premium members only.

The historical data trend for Voyager Therapeutics's Change In Inventory can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Voyager Therapeutics Change In Inventory Chart

Voyager Therapeutics Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Change In Inventory
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Voyager Therapeutics Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Change In Inventory Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
MEX:VYGR
52GF Score
Voyager Therapeutics Inc MEX:VYGR
Change In Inventory is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Voyager Therapeutics Change In Inventory Calculation

Change In Inventory is the difference between last period's ending inventory and the current period's ending inventory.

Change In Inventory for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was MXN0.0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Change In Inventory →
What does a Change In Inventory of MXN0.0 Mil mean?
Voyager Therapeutics (MEX:VYGR) has a Change In Inventory of MXN0.0 Mil as of Jun. 2026. Change in Inventory is the difference between current-period inventory and past-period inventory. View historical data for Voyager Therapeutics and its competitors.
Is Voyager Therapeutics' Change In Inventory too high?
Voyager Therapeutics' current Change In Inventory is MXN0.0 Mil. Overall, Voyager Therapeutics has a GF Score™ of 52/100, reflecting its overall financial health beyond just this single metric.
How does Voyager Therapeutics' Change In Inventory compare to NERV and DTIL?
Voyager Therapeutics' Change In Inventory of MXN0.0 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Change In Inventory for a Biotechnology company?
A good Change In Inventory depends on the Biotechnology industry context. However, Change In Inventory should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Change In Inventory mean?
A high Change In Inventory can signal that a stock is expensive relative to its fundamentals. Change in Inventory is the difference between current-period inventory and past-period inventory. View historical data for Voyager Therapeutics and its competitors. Voyager Therapeutics's current Change In Inventory is MXN0.0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Voyager Therapeutics stock overvalued right now?
Voyager Therapeutics (MEX:VYGR) has a current Change In Inventory of MXN0.0 Mil. The stock's GF Value™ is MXN30.50, compared to a current price of MXN63.00 — trading 106.6% above its estimated fair value. The current Change In Inventory is MXN0.0 Mil. Voyager Therapeutics' overall GF Score™ is 52/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Change In Inventory calculated?
Change In Inventory is calculated from a company's financial statements. For Voyager Therapeutics (MEX:VYGR), the current Change In Inventory is MXN0.0 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Voyager Therapeutics (MEX:VYGR) Overvalued in 2026?

Based on GuruFocus' analysis, Voyager Therapeutics stock appears to be overvalued. The current stock price of MXN63.00 is trading 106.6% above its estimated GF Value™ of MXN30.50.

Key valuation signals for MEX:VYGR:

  • Change In Inventory: MXN0.0 Mil
  • GF Value™: MXN30.50 vs. price of MXN63.00 (106.6% above fair value)
  • GF Score™: 52/100 with 6 warning signs

No single metric tells the full story. See the MEX:VYGR stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Voyager Therapeutics Business Description

Other Exchanges VYGR:USAVT6:Germany
Address 75 Hayden Avenue, Lexington, MA, USA, 02421
Voyager Therapeutics Inc is a biotechnology company to leverage the power of human genetics to modify the course of and ultimately cure neurological diseases. Its pipeline includes programs for Alzheimer's disease, or AD; Friedreich's ataxia, or FA; Parkinson's disease, or PD; and multiple other diseases of the central nervous system, or CNS. Many of its programs are derived from its TRACER (Tropism Redirection of AAV by Cell-type-specific Expression of RNA) adeno-associated virus, or AAV, capsid discovery platform, which the company has used to generate novel capsids, or TRACER Capsids, and identify associated receptors to potentially enable high brain penetration with genetic medicines following intravenous, or IV, dosing. Its segment is developing and commercializing genetic medicine.
52GF Score

Get the complete analysis for MEX:VYGR

Change In Inventory is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

MXN63.00
Price
MXN30.50
GF Value